Global Information
회사소개 | 문의 | 비교리스트

세계의 POC 분자진단(mPOC) 기기 시장(2020-2024년)

Global Molecular Point of Care (mPOC) Devices Market 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2020년 04월 상품 코드 934838
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 3,002,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,603,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,804,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,005,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 POC 분자진단(mPOC) 기기 시장(2020-2024년) Global Molecular Point of Care (mPOC) Devices Market 2020-2024
발행일 : 2020년 04월 페이지 정보 : 영문 120 Pages

세계 POC 분자진단(mPOC) 기기 시장은 2020-2024년간의 예측기간 동안 15%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 8억 1,662만 달러 규모에 달할 전망입니다. 감염증 유병률 증가와 인수합병(M&A) 활동 증가 등이 시장 성장 주요인입니다.

세계의 POC 분자진단(mPOC) 기기 시장에 대해 조사 분석했으며, 시장 규모 및 성장률, 시장 동향, 시장 성장 촉진요인, 과제, 시장 기회 분석, 주요 벤더 등에 대해 체계적인 정보를 전해드립니다.

목차

개요

시장 상황

시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2019년)
  • 시장 전망 : 예측(2019-2024년)

Five Forces 분석

용도별 시장 세분화

  • 시장 세분화
  • 용도별 비교 : 시장 규모 예측(2019-2024년)
  • 감염
  • 종양학
  • 기타
  • 용도별 시장 기회

고객 상황

  • 개요

지역별 상황

  • 지역별 세분화
  • 지역별 비교 : 시장 규모 예측(2019-2024년)
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 주요 국가
  • 지역별 시장 기회
  • 수량 성장요인 - 수요 중심 성장
  • 수량 성장요인 - 공급 중심 성장
  • 수량 성장요인 - 외부 요인
  • 시장의 과제
  • 시장 동향

벤더 상황

  • 개요
  • 파괴적 혁신

벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Credo Biomedical Pte. Ltd.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN NV
  • QuantuMDx Group Ltd.

부록

LSH 20.05.15

Technavio has been monitoring the molecular point of care (mPOC) devices market and it is poised to grow by $ 816.62 million during 2020-2024 progressing at a CAGR of 15% during the forecast period. Our reports on molecular point of care (mPOC) devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic and infectious diseases and the increasing number of M&A activities.

The molecular point of care (mPOC) devices market analysis includes application segment and geographic landscapes

Technavio's ‘ molecular point of care (mPOC) devices market is segmented as below

By Application

  • Infectious diseases
  • oncology
  • others

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising number of product launches as one of the prime reasons driving the molecular point of care (mPOC) devices market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our molecular point of care (mPOC) devices market covers the following areas:

  • Molecular point of care (mPOC) devices market sizing
  • Molecular point of care (mPOC) devices market forecast
  • Molecular point of care (mPOC) devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular point of care (mPOC) devices market vendors that include Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd. Also, the molecular point of care (mPOC) devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019-2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Infectious diseases - Market size and forecast 2019-2024
  • Oncology - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Credo Biomedical Pte. Ltd.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Meridian Bioscience Inc.
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Infectious diseases - Market size and forecast 2019-2024 ($ million)
  • 24: Infectious diseases - Year-over-year growth 2019-2024 (%)
  • 25: Oncology - Market size and forecast 2019-2024 ($ million)
  • 26: Oncology - Year-over-year growth 2019-2024 (%)
  • 27: Others - Market size and forecast 2019-2024 ($ million)
  • 28: Others - Year-over-year growth 2019-2024 (%)
  • 29: Market opportunity by Application
  • 30: Customer landscape
  • 31: Market share by geography 2019-2024 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2019-2024 ($ million)
  • 34: North America - Year-over-year growth 2019-2024 (%)
  • 35: Europe - Market size and forecast 2019-2024 ($ million)
  • 36: Europe - Year-over-year growth 2019-2024 (%)
  • 37: Asia - Market size and forecast 2019-2024 ($ million)
  • 38: Asia - Year-over-year growth 2019-2024 (%)
  • 39: ROW - Market size and forecast 2019-2024 ($ million)
  • 40: ROW - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Abbott Laboratories - Overview
  • 50: Abbott Laboratories - Business segments
  • 51: Abbott Laboratories - Key offerings
  • 52: Abbott Laboratories - Key customers
  • 53: Abbott Laboratories - Segment focus
  • 54: bioMerieux SA - Overview
  • 55: bioMerieux SA - Business segments
  • 56: bioMerieux SA - Key offerings
  • 57: bioMerieux SA - Key customers
  • 58: bioMerieux SA - Segment focus
  • 59: Bio-Rad Laboratories Inc. - Overview
  • 60: Bio-Rad Laboratories Inc. - Business segments
  • 61: Bio-Rad Laboratories Inc. - Key offerings
  • 62: Bio-Rad Laboratories Inc. - Key customers
  • 63: Bio-Rad Laboratories Inc. - Segment focus
  • 64: Credo Biomedical Pte. Ltd. - Overview
  • 65: Credo Biomedical Pte. Ltd. - Product and service
  • 66: Credo Biomedical Pte. Ltd. - Key offerings
  • 67: Credo Biomedical Pte. Ltd. - Key customers
  • 68: Credo Biomedical Pte. Ltd. - Segment focus
  • 69: Danaher Corp. - Overview
  • 70: Danaher Corp. - Business segments
  • 71: Danaher Corp. - Key offerings
  • 72: Danaher Corp. - Key customers
  • 73: Danaher Corp. - Segment focus
  • 74: F. Hoffmann-La Roche Ltd. - Overview
  • 75: F. Hoffmann-La Roche Ltd. - Business segments
  • 76: F. Hoffmann-La Roche Ltd. - Key offerings
  • 77: F. Hoffmann-La Roche Ltd. - Key customers
  • 78: F. Hoffmann-La Roche Ltd. - Segment focus
  • 79: Meridian Bioscience Inc. - Overview
  • 80: Meridian Bioscience Inc. - Business segments
  • 81: Meridian Bioscience Inc. - Key offerings
  • 82: Meridian Bioscience Inc. - Key customers
  • 83: Meridian Bioscience Inc. - Segment focus
  • 84: Oxford Nanopore Technologies Ltd. - Overview
  • 85: Oxford Nanopore Technologies Ltd. - Product and service
  • 86: Oxford Nanopore Technologies Ltd. - Key offerings
  • 87: Oxford Nanopore Technologies Ltd. - Key customers
  • 88: Oxford Nanopore Technologies Ltd. - Segment focus
  • 89: QIAGEN N.V. - Overview
  • 90: QIAGEN N.V. - Business segments
  • 91: QIAGEN N.V. - Key offerings
  • 92: QIAGEN N.V. - Key customers
  • 93: QIAGEN N.V. - Segment focus
  • 94: QuantuMDx Group Ltd. - Overview
  • 95: QuantuMDx Group Ltd. - Product and service
  • 96: QuantuMDx Group Ltd. - Key offerings
  • 97: QuantuMDx Group Ltd. - Key customers
  • 98: QuantuMDx Group Ltd. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations
Back to Top
전화 문의
F A Q